NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

ZCMD

Zhongchao Inc

Jul 08 • 12:36PM ET

1.14

Dollar change +0.01
Percentage change 0.88	%

Healthcare • Health Information Services • China • NASD

Peers: BNTX CRSP ARWR EDIT ACHV FATE AXSM CLLS APRE

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.12	Insider Own	27.34%	Shs Outstand	24.84M	Perf Week	-5.79%
Market Cap	28.79M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	18.35M	Perf Month	6.54%
Enterprise Value	19.08M	PEG	-	EPS next Q	-	Inst Own	0.11%	Short Float	1.16%	Perf Quarter	-12.98%
Income	-0.64M	P/S	1.82	EPS this Y	-	Inst Trans	12.90%	Short Ratio	0.88	Perf Half Y	-43.53%
Sales	15.86M	P/B	1.39	EPS next Y	-	ROA	-2.56%	Short Interest	0.21M	Perf YTD	-29.63%
Book/sh	0.82	P/C	2.20	EPS next 5Y	-	ROE	-3.31%	52W High	2.97 -61.62%	Perf Year	-0.87%
Cash/sh	0.52	P/FCF	-	EPS past 3/5Y	- -	ROIC	-3.08%	52W Low	0.95 20.00%	Perf 3Y	-91.02%
Dividend Est.	-	EV/EBITDA	212.03	Sales past 3/5Y	-0.89% 1.29%	Gross Margin	56.18%	Volatility	9.52% 12.48%	Perf 5Y	-94.84%
Dividend TTM	-	EV/Sales	1.20	EPS Y/Y TTM	97.16%	Oper. Margin	-2.15%	ATR (14)	0.13	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	11.79	Sales Y/Y TTM	-18.37%	Profit Margin	-4.05%	RSI (14)	47.40	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	12.22	EPS Q/Q	93.79%	SMA20	-5.75%	Beta	-0.06	Target Price	-
Payout	-	Debt/Eq	0.00	Sales Q/Q	-17.02%	SMA50	-3.59%	Rel Volume	0.05	Prev Close	1.13
Employees	111	LT Debt/Eq	0.00	Earnings	-	SMA200	-19.13%	Avg Volume	240.87K	Price	1.14
IPO	Feb 24, 2020	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	6,033	Change	0.88%

Apr-19-24 08:27AM	Why Is Zhongchao (ZCMD) Stock Up 103% Today? (InvestorPlace) +33.79%
Apr-04-24 08:12AM	Why Is Zhongchao (ZCMD) Stock Up 40% Today? (InvestorPlace) +24.68%
Mar-12-24 08:30AM	Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications (PR Newswire) +13.16%
Mar-05-24 07:54AM	Why Is Zhongchao (ZCMD) Stock Up 15% Today? (InvestorPlace) -17.30%
Feb-27-24 08:00AM	Zhongchao Inc. Announces 1-for-10 Share Consolidation (PR Newswire) +12.89%
08:00AM	Loading…
Dec-11-23 08:00AM	Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments (PR Newswire) -31.03%
Oct-23-23 08:00AM	Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day (PR Newswire)
Sep-25-23 08:00AM	Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients (PR Newswire)
Aug-24-23 08:00AM	Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management (PR Newswire)
Jul-11-23 08:00AM	Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer Education (PR Newswire) +6.73%
Jun-12-23 08:00AM	Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment (PR Newswire)
May-12-23 08:00AM	Zhongchao Inc. Announces Strategic Cooperation with Ximalaya (PR Newswire)
May-08-23 08:00AM	Zhongchao Inc. Announces Naiditawei® Enrolled as a Listed Online Procurement Drug in Ten Provinces(Districts, Cities) in China (PR Newswire)
Apr-24-23 08:00AM	Zhongchao Inc. Partners with a Public Health Foundation to Safeguard Cancer Patients' Health (PR Newswire)
Mar-30-23 08:00AM	Zhongchao Inc. Announces Launch of Health Education Intelligent Content Production Platform (PR Newswire)
08:00AM	Loading…
Mar-13-23 08:00AM	Zhongchao Inc. Releases Survey Results for Bone Marrow Cancer Patient Services with More than 80% Patients Indicating Full Satisfaction (PR Newswire)
Feb-23-23 08:00AM	Zhongchao Inc. Renews Partnership with Johnson & Johnson (China) (PR Newswire)
Feb-13-23 09:20AM	Zhongchao Inc. Announces the Application of ChatGPT for Its MDMOOC Platform to Assist Physicians in Clinic Decision Making and Improve Treatment Efficiency (PR Newswire)
Feb-08-23 07:30AM	Zhongchao Inc. Announces the Application of ChatGPT to Elevate Patient Management Service Capabilities and Experience (PR Newswire) +19.28%
Jan-31-23 07:30AM	Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China (PR Newswire)
Jan-19-23 07:30AM	Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment (PR Newswire)
Jan-04-23 07:30AM	Zhongchao Inc. Announces Drug Distributorship in China of Indian Generic Drugs of Natco Pharma Limited (PR Newswire)
Dec-18-22 07:21AM	Zhongchao First Half 2022 Earnings: EPS: US$0.004 (vs US$0.04 in 1H 2021) (Simply Wall St.)
Dec-05-22 07:30AM	Zhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education Platform (PR Newswire)
Nov-03-22 07:30AM	Zhongchao Inc.'s China Operating Entity, Chongqing Xinjiang Pharmaceutical Co., Ltd. Obtained Pharmaceutical Trade and Medical Device Operation Licenses, Ready to Enter Into Pharmaceuticals Circulation Market (PR Newswire)
Sep-28-22 09:18AM	Zhongchao Inc. Establishes Chongqing Xinjiang Pharmaceutical Co., Ltd. to Improve Patient Access to Medications (PR Newswire) -6.78%
Sep-15-22 07:30AM	Zhongchao Inc. Establishes Zhixun Internet Hospital to Provide Patient with Management Services Focusing on the Oncology and Other Major Diseases (PR Newswire)
Sep-01-22 07:30AM	Zhongchao Inc. Announces its New Strategy Extension Focusing on the Oncology and Other Major Disease Management (PR Newswire)
Jun-13-22 06:30AM	Zhongchao Inc. Announces its MDMOOC Platform Launched Disease Prevention and Distribution Quality Management Course (PR Newswire) -10.57%
May-09-22 06:30AM	Zhongchao Inc. Reports the Fiscal Year 2021 Financial Results (PR Newswire)
06:07PM	Loading…
Mar-21-22 06:07PM	Could The Market Be Wrong About Zhongchao Inc. (NASDAQ:ZCMD) Given Its Attractive Financial Prospects? (Simply Wall St.) +13.60%
Dec-21-21 12:40PM	Capital Allocation Trends At Zhongchao (NASDAQ:ZCMD) Aren't Ideal (Simply Wall St.)
Oct-29-21 06:30AM	Zhongchao Inc. Announces Its Patient Management System Improves Its Liver Cancer Patients' Duration of Therapy by 40%, Promoting Successful Treatment (PR Newswire)
Sep-17-21 06:30AM	Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and Treatment (PR Newswire)
Sep-14-21 12:08PM	Can Zhongchao Inc. (NASDAQ:ZCMD) Maintain Its Strong Returns? (Simply Wall St.)
Sep-10-21 06:30AM	Zhongchao Inc. Announces Hematological Tumor Patient Management Business to Further Expand to Out-of-Hospital Market (PR Newswire)
Aug-25-21 08:30AM	Zhongchao Inc. Expands Patient Management Business to Ovarian Cancer Market (PR Newswire)
Aug-12-21 08:30AM	Zhongchao Inc. Builds A Patient DOT Management System (PR Newswire)
Jul-27-21 08:30AM	Zhongchao Inc. Builds A Platform for Breast Cancer Tiered Diagnosis and Treatment Improvement To Promote the Equalization of Breast Cancer Diagnosis and Treatment Level (PR Newswire)
Jul-14-21 08:23AM	Zhongchao (NASDAQ:ZCMD) May Have Issues Allocating Its Capital (Simply Wall St.)
Jul-01-21 08:30AM	Zhongchao Inc. Announces the Establishment of a New Subsidiary Ningxia Zhongxin Internet Hospital Co., Ltd. for Patient Management (PR Newswire)
Jun-16-21 06:30AM	Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for Medical Education Services (PR Newswire)
Jun-03-21 06:30AM	Zhongchao Inc. Announces the On-Going One-Year Leukemia Education Project with Bethune Foundation and BeiGene Shanghai (PR Newswire)
May-28-21 06:30AM	Zhongchao Inc. Launched New Line of Business Focusing on Tumor and Rare Disease Patient Management (PR Newswire) -5.88%
May-12-21 10:42AM	Market Still Lacking Some Conviction On Zhongchao Inc. (NASDAQ:ZCMD) (Simply Wall St.)
Apr-30-21 09:00AM	Zhongchao Inc. Reports the Fiscal Year 2020 Financial Results (PR Newswire)
Mar-17-21 06:30AM	Zhongchao Renews Contract with China Association of Health Promotion and Education and GlaxoSmithKline (PR Newswire) +46.15%
Mar-04-21 11:45AM	ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Zhongchao Inc. and Encourages Investors with Losses to Contact the Firm (Newsfile) -13.47%
Feb-23-21 07:20AM	Zhongchao's(NASDAQ:ZCMD) Share Price Is Down 44% Over The Past Year. (Simply Wall St.) -8.00%
Feb-10-21 05:10PM	IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zhongchao Inc. and Encourages Investors with Losses to Contact the Firm (ACCESSWIRE)
Feb-01-21 05:10PM	ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Zhongchao Inc. and Encourages Investors with Losses to Contact the Firm (PR Newswire)
Jan-27-21 02:30PM	ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zhongchao Inc. and Encourages Investors with Losses to Contact the Firm (ACCESSWIRE) -6.19%
Jan-13-21 01:00PM	SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Zhongchao Inc. and Encourages Investors with Losses to Contact the Firm (ACCESSWIRE)
06:30AM	Zhongchao Inc. Promotes Standardized Liver Cancer Diagnosis and Treatment with Medical Associations and Experts (PR Newswire)
Jan-12-21 03:06PM	ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zhongchao Inc. and Encourages Investors with Losses to Contact the Firm (PR Newswire)
Jan-11-21 04:23PM	INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Zhongchao Inc. and Encourages Investors with Losses to Contact the Firm (Business Wire)
Jan-08-21 07:29PM	INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zhongchao Inc. and Encourages Investors with Losses to Contact the Firm (Business Wire)
Nov-12-20 06:30AM	Zhongchao Inc. and Takeda Pharmaceutical Expand Scope of Cooperation in China (PR Newswire) +14.36%
Sep-23-20 01:21PM	Should We Be Delighted With Zhongchao Inc.'s (NASDAQ:ZCMD) ROE Of 14%? (Simply Wall St.)
Sep-21-20 09:21AM	Zhongchao Inc. Reports the First Half of Fiscal Year 2020 Financial Results (PR Newswire)
Aug-21-20 06:59AM	Zhongchao Inc. Offers Advanced Workshops in Partnership with European Wound Management Association (EWMA) (PR Newswire)
Aug-11-20 06:30AM	Zhongchao Inc. Develops Live Interactive Courses Promoting the Global Initiative for Chronic Obstructive Lung Disease (PR Newswire)
Aug-04-20 07:27AM	Zhongchao Inc. Renews Contract with Johnson & Johnson (China) Limited, Extending the Cooperation since 2017 (PR Newswire) +18.75%
Jul-23-20 06:30AM	Zhongchao Inc. Joined Hands with Professional Non-Profit Organizations and 9 Leading Pharma Companies to Carry Out Multi-Year Online Education Project on Diagnosis and Treatment of Primary Liver Cancer (PR Newswire)
Jul-10-20 06:30AM	Zhongchao Inc. Co-organizes China-Russia-Near East Gastrointestinal Academic Dialogue (PR Newswire)
Jul-06-20 06:30AM	Zhongchao Inc. Launches Patient Management Services (PR Newswire) +5.56%
Jun-08-20 07:00AM	Zhongchao Inc. Partners with WentzMiller for Expansion in the U.S. (PR Newswire) +9.05%
May-08-20 06:30AM	Zhongchao Inc. Reports Fiscal Year 2019 Financial Results (PR Newswire)
Apr-24-20 06:00AM	Zhongchao Inc. Launches COVID-19 Knowledge and Experience Sharing Virtual Seminar Series for Global Healthcare Professionals (PR Newswire)
Apr-01-20 06:30AM	Zhongchao Inc. Achieves Accumulative 5.1 Million Subscribers and 1.3 Billion Click-Throughs for Its Sunshine Health Forums Platform (PR Newswire) -9.80%
Mar-23-20 06:30AM	Zhongchao Inc. Provides Update on COVID-19 (Coronavirus) Impact (PR Newswire) +13.40%
Mar-02-20 06:30AM	Zhongchao Inc. Announces Partial Exercise of the Underwriter's Over-Allotment Option for Its Firm Commitment Public Offering (PR Newswire) -7.93%
Feb-21-20 09:05PM	Zhongchao Inc. Announces Pricing of $12 Million Firm Commitment Initial Public Offering (PR Newswire)

Zhongchao, Inc. is a holding company, which engages in the provision of healthcare information, education, and training services. It operates under the Services and Drugs segments. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, articles, and short videos with educational healthcare content to healthcare professionals as well as the public. The company was founded by Wei Guang Yang on August 17, 2012 and is headquartered in Shanghai, China.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ZCMD

Zhongchao Inc

Upgrade your FINVIZ experience